[Studies on amikacin (BB-K8), a new aminoglycoside antibiotic (author's transl)].
D000328:Adult; D000368:Aged; D000613:Aminobutyrates / Q000031:analogs & derivatives / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects*; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000150:complications / Q000188:drug therapy; D004341:Drug Evaluation; D004653:Empyema / Q000188:drug therapy; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007612:Kanamycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications; D011014:Pneumonia / Q000150:complications / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy*
D000613:Aminobutyrates; D007612:Kanamycin